StockData
AbbVie Inc. logo

AbbVie Inc. (ABBV) operating KPIs

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)

Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%

AbbVie level 3 Rollforward — Additions ($M) ($M)

Form 10-Q / 10-K Fair Value Measurements Note

QuarterlyAnnual
Latest, Q2 2026
0
Period ended Jun 30, 2026
Change on a year earlier
–
0 in Q2 2025
History
20 quarters
Since Q3 2016
Sources
14
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedLevel 3 Rollforward — Additions ($M) ($M)Year on yearSource
Q2 2026Jun 30, 20260–Form 10-Q (filed 2026-08-03) ↗
Q1 2026Mar 31, 20260-100.0%Form 10-Q (filed 2026-05-08) ↗
Q4 2025Dec 31, 20250–Form 10-K (filed 2026-02-20) ↗
Q3 2025Sep 30, 20250–Form 10-Q (filed 2025-11-04) ↗
Q2 2025Jun 30, 20250–Form 10-Q (filed 2026-08-03) ↗
Q1 2025Mar 31, 202578–Form 10-Q (filed 2026-05-08) ↗
Q4 2024Dec 31, 20240–Form 10-K (filed 2026-02-20) ↗
Q3 2024Sep 30, 20240–Form 10-Q (filed 2025-11-04) ↗
Q2 2024Jun 30, 20240–Form 10-Q (filed 2025-08-04) ↗
Q1 2024Mar 31, 20240–Form 10-Q (filed 2025-05-09) ↗
Q4 2021Dec 31, 20210-100.0%Form 10-K (filed 2024-02-20) ↗
Q3 2021Sep 30, 20210–Form 10-Q (filed 2021-11-02) ↗
Q4 2020Dec 31, 2020104–Form 10-K (filed 2023-02-17) ↗
Q3 2020Sep 30, 20200–Form 10-Q (filed 2021-11-02) ↗
Q4 2019Dec 31, 20190–Form 10-K (filed 2022-02-18) ↗
Q3 2019Sep 30, 20190–Form 10-Q (filed 2020-11-04) ↗

Cite this data

StockData. (2026). AbbVie Level 3 Rollforward — Additions ($M) ($M), quarterly Q3 2016–Q2 2026 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/cc_additions

See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.